Public health. Treating vaccine reactions: two lifelines, but no guarantees.
Enserink
Martin
M
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D000077404:Cidofovir; D002986:Clinical Trials as Topic; D003596:Cytosine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D004673:Encephalomyelitis, Acute Disseminated / Q000188:drug therapy / Q000209:etiology / Q000628:therapy; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000008:administration & dosage / Q000627:therapeutic use*; D007617:Kaposi Varicelliform Eruption / Q000188:drug therapy / Q000209:etiology / Q000628:therapy; D051379:Mice; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D012307:Risk Factors; D012900:Smallpox Vaccine / Q000009:adverse effects*; D014615:Vaccinia / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D014616:Vaccinia virus / Q000276:immunology*
D000998:Antiviral Agents; D007136:Immunoglobulins; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D012900:Smallpox Vaccine; D003596:Cytosine; D000077404:Cidofovir